Crossmark

Metformin administration is associated with enhanced response to transarterial chemoembolization for hepatocellular carcinoma in type 2 diabetes patients

Crossref DOI link: https://doi.org/10.1038/s41598-022-18341-2

Published Online: 2022-08-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Jung, Woo Jin

Jang, Sangmi

Choi, Won Joon

Park, Jaewon

Choi, Gwang Hyeon https://orcid.org/0000-0002-8795-8427
Jang, Eun Sun https://orcid.org/0000-0003-4274-2582
Jeong, Sook-Hyang https://orcid.org/0000-0002-4916-7990
Choi, Won Seok

Lee, Jae Hwan

Yoon, Chang Jin

Kim, Jin-Wook https://orcid.org/0000-0003-0934-3344
Funding

Funding for this research was provided by:

Seoul National University Bundang Hospital/SK Telecom (06-2013-104)
License Information

Text and Data Mining valid from 2022-08-25

Version of Record valid from 2022-08-25
More Information

Article History

Received: 15 December 2021

Accepted: 9 August 2022

First Online: 25 August 2022

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below